Effect of partially modified retro-inverso analogues derived from C-reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages

British Journal of Pharmacology

Volumn 120, Issue 7, 1997, Pages 1383-1389

  Arcoleo, F ^a   Milano, S ^a   D'Agostino, P ^a   Misiano, G ^a   Cappelletti, S ^b   Gromo, G ^c   Marcucci, F ^b   Leoni, F ^b   Cillari, E ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Italfarmaco SpA   (Italy)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Interleukin 1 (IL 1); Nitric oxide; Nitric oxide synthase; Tumour necrosis factor (TNF )

Indexed keywords

C REACTIVE PROTEIN; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; NITRIC OXIDE; PYRROLIDINE DERIVATIVE; TETRAPEPTIDE; TUFTSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; FEMALE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; C-REACTIVE PROTEIN; CELLS, CULTURED; DEXAMETHASONE; FEMALE; INTERLEUKIN-1; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030932777     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701050     Document Type: Article

References (48)

1. AGRAWAL, A. & VOLONAKIS, J.E. (1994). Probing the Clq-binding site on human C-reactive protein by site-directed mutagenesis. J. Immunol., 152, 5404 - 5410.
2. BABCOCK, G.F., AMOSCATO, A.A. & NISHIOKA, K. (1983). Effect of tuftsin on the migration, chemotaxis, and differentiation of macrophages and granulocytes. Ann. New York Acad. Sci., 419, 64 - 74.
3. BALDWIN, A.S. JR. (1996). The NF-κB and IκB protein: new discoveries and insights. Annu. Rev. Immunol., 14, 649 - 681.
4. BALLOU, S.P. & KUSHNER, I. (1992). C-reactive protein and the acute phase response. Adv. Intern. Med., 37, 313 336.
5. BAEUERLE, P.A. & HENKEL, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12, 141 179.
6. BAUMANN, H. & GAULDIE, J. (1994). The acute phase response. Immunol. Today. 15, 74 - 80.
7. BEASLEY, D., SCHWARTZ, J.H. & BRENNER, B.M. (1991). Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest., 87, 602 - 608.
8. BONELLI, F. PESSI, A. & VERDINI, A.S. (1984). Solid phase synthesis of retro-inverso peptide-analogues. Int. J. Peptide Protein Res., 24, 553 - 556.
9. CATANE R., SCHLANGER, S., WEISS, L., PENCHAS, S., FUKS, Z., TREVES, A.J., GOTTLIEB, P. & FRIDKIN, M. (1983). Toxicology and antitumor activity of tuftsin. Ann. New York Acad. Sci., 419, 251 - 260.
10. CILLARI, E., ARCOLEO, F., DIELI, M., D'AGOSTINO, R., GROMO, G., LEONI, F. & MILANO, S. (1994). The macrophage-activating telrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro. Infect. Immun., 62, 2649 2652.
11. DING, A.H., NATHAN, C.F. & STUEHR, D.J. (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol., 141, 2407 - 2412.
12. DRAPIER, J.C., WIETZERBIN, J. & HIBBS, J.B. (1988). Interferon-gamma and tumour necrosis factor induce the L-arginine dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol., 18, 1587 1592.
13. D'SOUZA, S.A., GINSBERG, M.H. & PLOW, E.F. (1991). Arginyl-glycyl-aspartic acid (RDG): a cell adhesion motif. Trends Biochem. Sci., 16, 246 250.
14. FIEDEL, B.A. (1988). Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour. Immunology, 64, 487 - 493.
15. FRIDKIN, M. & GOTTLIEB, P. (1981). Tuftsin, Thr-Lys-Pro-Arg anatomy of an immunologically active peptide. Mol. Cell Biochem., 41, 73 - 97.
16. FRIDKIN, M. & NAJJAR, V. (1989). Tuftsin. Its chemistry, biology and clinical potential. Crit. Rev. Biochem. Mol. Biol., 24, 1 - 40.
17. GOODMAN, M. & CHOREV, M. (1979). On the concept of linear modified retro-peptide structures. Acc. Chem. Res., 12, 1 - 7.
18. GROGGIA, A., PESSI, A., SISTO, A., VERDINI, A.S., VIRDIA, A. & VISCOMI, G.C. (1985). Effects of the peptide bond retro-inversion on the biological activity of Bradykinin Potentiating Peptide 5a (BPP5a). In Peptide: Structure and Function (Proc. 9th American Peptide Symposium pp. 659 662. Rockford, IL, U.S.A. Pierce Chemical Company.
19. HEUERTZ, R.M., AHMED, N. & WEBSTER, O.R. (1996). Peptides derived from C-reactive protein inhibit neutrophil alveolitis. J. Immunol., 156, 3412 3417.
20. HIBBS, J.B. JR., TAINTOR, R.R., VAVRIN, Z., GRANGER, D.L., DRAPIER, J.C. AMBER, I.J. & LANCASTER, J.R. JR. (1990). Synthesis of nitric oxide from a terminal guanidino atom of L-arginine: a molecular mechanism regulating cellular proliferation that target intracellular iron. In Nitric Oxide from L-Arginine: A Bioregulatory System. ed Moncada, S. & Higgs. E.A. pp. 189 223. Amsterdam; Elsevier.
21. LAEMMLI, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680 - 685.
22. LOWENTHAL, J.W., BALLARD, D.W., BOHNLEIN, E. & GREEN, W.C. (1989). Tumor necrosis factor α induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin 2 receptor α-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A., 86, 2331 2335.
23. MARTINEZ, J. & WINTERNITZ, F.(1981). Bacterial activity of tuftsin. Mol. Cell. Biochem., 41, 123 - 136.
24. MORLEY, J.J. & KUSHNER, I. (1982). Serum C-reactive protein levels in disease. Ann. New York Acad. Sci., 389, 406 418.
25. MORTENSEN, R.F., OSMAND, A.P., LINT, T.F. & GEWURZ, H. (1976). Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. J. Immunol., 117, 774 781.
26. MOSSMAN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods, 65, 55 - 61.
27. MULLENIX, M.C., KAUMAYA, P.T.P. & MORTENSEN, R.F. (1994). Cell attachment peptide of C-reactive protein critical amino acids and minimum length. J. Cell Biochem., 54, 343 - 353.
28. MULLER, J.M., ZI, A.M., HUANG, C.K. & HUBER, B.T. (1993). Interleukin-1 induces protein tyrosine phosphorylation. Eur. J. Immunol., 22, 2101 - 2106.
29. NAJJAR, V.A. & NISHIUOKA, K. (1970). Tuftsin an unphysiological phagocytosis-stimulating peptide. Nature. 288, 672 - 673.
30. NISHIOKA, K., AMOSCATO, A.A. & BABCOCK, G.F. (1981). Tuftsin: a hormone-like tetrapeptide with antimicrobial and antitumor activities. Life Sci., 28, 1081 - 1090.
31. NISHIOKA, K., HOPFER, R.L., EL-HAGIN, T. & LOPEZ-BERENSTEINS, G. (1986). Prophylaxis of Candida albicans infection with tuftsin. J. Antimicrobiol Chemother., 17, 361 - 366.
32. NOVOGRODSKY, A., VANICHKIN, A., PATYA, M., GARIT., A., OSHEROV, A. & LEVITZKI, A. (1994). Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science, 264, 1319 - 1322.
33. OSBORN, L., KUNKEL, S. & NABEL, G.J. (1989). Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U.S.A., 86, 2336 2340.
34. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664 - 666.
35. PENG, H.B., LIBBY, P. & LIAO, J. (1995). Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem., 270, 214 - 219.
36. PEPYS, M.B. & BALTZ, M.L. (1983). Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34, 141 - 212.
37. PLISKA, V. (1994). Models to explain dose-response relationships that exhibit a downturn phase. Trends Pharmacol. Sci., 15, 178 - 181.
38. ROBEY, F.A., OHURA, K., FUTAKI, S., FUJII, N., YAJIMA, H., GOLDMAN, N., JONES, K.D. & WAHL, S. (1987). Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. J. Biol. Chem., 262, 7053 - 7057.
39. ROVATI, G.E. & NICOSIA, S. (1994). Lower efficacy: interaction with an inhibitory receptor or partial agonism? Trends Pharmacol. Sci, 15, 140 144.
40. SAKUMA, L., STUEHR, D.J., GROSS, S., NATHAN, C.F. & LEVI, R. (1988). Identification of arginine as a precursor of endothelial derived relaxing factor (EDRF). Proc. Natl. Acad. Sci. U.S.A., 85, 8664 - 8667.
41. 2+-independent nitric oxide synthases. FEBS Lett., 291, 145 149.
42. SCHRECK, R., MEIER, B., MANNEL, D.N., DROGE, W. & BALUERLE, P.A. (1992). Dithiocarbamates as potent inhibitors of nuclear factor kB activation in intact cells. J. Exp. Med., 175, 1181 - 1194.
43. SMITH, P.C., ZAM, S. & STERN, G.A. (1986). The effect of tuftsin in the treatment of experimental Pseudomonas keratites. Cornea, 5, 181 183.
44. SPIRER, Z., ZAKUTH, V., GOLANDER, A., BOGAIR, N. & FRIDKIN, M. (1975). The effect of tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes. J. Clin. Invest., 55, 198 - 200.
45. STEEL, D.M. & WHITEHEAD, A.S. (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today. 15, 81 - 88.
46. 2 modification. J. Med. Chem., 34, 3372 - 3379.
47. WEIGMANN, K., SCHUTZE, S., MACHLEIDT, T., WITTE, D. & KRONKE, M. (1994). Functional dichotomy of neutral and acidic sphingomyelinases in TNF signaling. Cell, 78, 1005 - 1114.
48. ZEIHER, A., FISSLTHALER, B., SCRAY-UTZ, B. & BUSSE, R. (1995). Nitric oxide modulates the expression of monocyte chemattractant protein 1 in cultured human endothelial cells. Circ. Res., 76, 980 - 986.